Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.
作者信息
Buetti Niccolò, Mazzuchelli Timothy, Lo Priore Elia, Balmelli Carlo, Llamas Michael, Pallanza Micol, Elzi Luigia, Consonni Vera, Trimboli Pierpaolo, Forni-Ogna Valentina, Bernasconi Enos
机构信息
Ente Ospedaliero Cantonale, Locarno Community Hospital, Locarno, Switzerland; INSERM IAME, U1137, Team DeSCID, Paris, France.
Ente Ospedaliero Cantonale, Locarno Community Hospital, Locarno, Switzerland.
出版信息
J Infect. 2020 Aug;81(2):e148-e149. doi: 10.1016/j.jinf.2020.06.004. Epub 2020 Jun 5.
Abstract
摘要
相似文献
1
Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.
J Infect. 2020 Aug;81(2):e148-e149. doi: 10.1016/j.jinf.2020.06.004. Epub 2020 Jun 5.
2
Response to "Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis".
Crit Care. 2020 Sep 29;24(1):591. doi: 10.1186/s13054-020-03308-4.
3
Is previous influenza-like illness a potential Trojan horse for COVID-19?
Crit Care. 2020 Aug 14;24(1):503. doi: 10.1186/s13054-020-03226-5.
4
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.
Br J Haematol. 2020 Nov;191(3):505-506. doi: 10.1111/bjh.17110. Epub 2020 Oct 26.
5
Comment to: Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection.
Einstein (Sao Paulo). 2020;18:eCE5931. doi: 10.31744/einstein_journal/2020ce5931. Epub 2020 Aug 5.
6
Cluster of chalazia in nurses using eye protection while caring for critically ill patients with COVID-19 in intensive care.
Occup Environ Med. 2020 Aug;77(8):584-585. doi: 10.1136/oemed-2020-106677. Epub 2020 May 28.
7
Re: Cluster of chalazia in nurses using eye protection while caring for critically ill patients with COVID-19 in intensive care.
Occup Environ Med. 2020 Nov;77(11):808. doi: 10.1136/oemed-2020-106871. Epub 2020 Aug 18.
8
Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): A comparative study.
J Infect. 2020 Aug;81(2):e82-e84. doi: 10.1016/j.jinf.2020.05.021. Epub 2020 May 13.
9
Critically ill patients with COVID-19 and candidaemia: We must keep this in mind.
J Mycol Med. 2020 Dec;30(4):101012. doi: 10.1016/j.mycmed.2020.101012. Epub 2020 Jul 4.
10
Thrombotic complications in critically ill patients with COVID 19.
Thromb Res. 2020 Jul;191:56. doi: 10.1016/j.thromres.2020.04.032. Epub 2020 Apr 30.
引用本文的文献
1
Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study.
Antibiotics (Basel). 2025 Jun 8;14(6):594. doi: 10.3390/antibiotics14060594.
2
The Impact of Early Antibiotic Use on Clinical Outcomes of Patients Hospitalized with COVID-19: A Propensity Score-Matched Analysis.
Infect Drug Resist. 2024 Aug 9;17:3425-3438. doi: 10.2147/IDR.S470957. eCollection 2024.
3
Antibacterial agents used in COVID-19: A systematic review and meta-analysis.
Environ Sustain (Singap). 2021;4(3):503-513. doi: 10.1007/s42398-021-00194-6. Epub 2021 Jun 7.
4
Coalescence of co-infection and antimicrobial resistance with SARS-CoV-2 infection: The blues of post-COVID-19 world.
Case Stud Chem Environ Eng. 2021 Jun;3:100093. doi: 10.1016/j.cscee.2021.100093. Epub 2021 Feb 21.
5
Characterization of Coinfections in Patients with COVID-19.
Can J Hosp Pharm. 2024 Jan 10;77(1):e3398. doi: 10.4212/cjhp.3398. eCollection 2024.
6
Predictors of intensive care unit admission in adult cancer patients presenting to the emergency department with COVID-19 infection: A retrospective study.
PLoS One. 2023 Aug 29;18(8):e0287649. doi: 10.1371/journal.pone.0287649. eCollection 2023.
7
Epidemiological Impact on Use of Antibiotics in Patients Hospitalized for COVID-19: A Retrospective Cohort Study in Italy.
Antibiotics (Basel). 2023 May 15;12(5):912. doi: 10.3390/antibiotics12050912.
8
Pharmacist-driven antimicrobial stewardship interventions in patients with COVID-19: a scoping review.
Int J Clin Pharm. 2023 Jun;45(3):613-621. doi: 10.1007/s11096-023-01574-0. Epub 2023 May 10.
9
Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial.
Lancet Infect Dis. 2023 Jun;23(6):673-682. doi: 10.1016/S1473-3099(22)00832-5. Epub 2023 Jan 27.
10
Increasing Consumption of Antibiotics during the COVID-19 Pandemic: Implications for Patient Health and Emerging Anti-Microbial Resistance.
Antibiotics (Basel). 2022 Dec 28;12(1):45. doi: 10.3390/antibiotics12010045.
本文引用的文献
1
Co-infections in people with COVID-19: a systematic review and meta-analysis.
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
2
Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?
Clin Infect Dis. 2020 Dec 17;71(10):2736-2743. doi: 10.1093/cid/ciaa524.
3
COVID-19: don't neglect antimicrobial stewardship principles!
Clin Microbiol Infect. 2020 Jul;26(7):808-810. doi: 10.1016/j.cmi.2020.04.024. Epub 2020 Apr 30.
4
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530.
5
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.
Lancet Infect Dis. 2020 Apr;20(4):425-434. doi: 10.1016/S1473-3099(20)30086-4. Epub 2020 Feb 24.
Zotero 插件